EMBC — Embecta Corp.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1872789 ·
Last close
$3.32
Market Cap
$196.97M
52W High
$10.34
52W Low
$2.77
ADV30
2,738,244
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 221,800,000 | 127,800,000 | 42,900,000 | -4,100,000 | 1,029,300,000 | 184,900,000 | 1,655,400,000 |
| Dec 2025 | 261,200,000 | 161,700,000 | 76,300,000 | 44,100,000 | 1,063,700,000 | 201,300,000 | 1,676,800,000 |
| Sep 2025 | 264,000,000 | 158,500,000 | 64,300,000 | 26,400,000 | 1,090,900,000 | 225,500,000 | 1,742,100,000 |
| Jun 2025 | 295,500,000 | 197,100,000 | 105,000,000 | 45,500,000 | 1,157,300,000 | 230,600,000 | 1,826,900,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$213,500,000
Investing CF
$1,300,000
Financing CF
$-237,300,000
CapEx
$-8,800,000
Dividends Paid
$-35,300,000
Buybacks
—
EPS Diluted TTM
$1.90
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-424,700,000
Inventory
$192,600,000
Receivables
$147,100,000
ST Investments
—
EBIT TTM
$269,000,000
Pretax Income TTM
$169,600,000
Interest Exp TTM
$99,400,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,042,499,968
EBITDA
$332,300,000
Free Cash Flow
$195,800,000
Enterprise Value
$1,384,567,936
Total Cash
$184,900,000
Total Debt
$1,372,499,968
Shares Out
59,327,677
Trailing EPS
$1.89
Book Value
$-10.55
ROE
—
ROA
16.8%
Div Yield
13.83%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 1,080,400,000 | 296,400,000 | 95,400,000 | 1,090,900,000 | 1,742,100,000 | — | 191,700,000 |
| Sep 2024 | 1,123,100,000 | 285,000,000 | 78,300,000 | 1,285,300,000 | 2,024,200,000 | — | 35,700,000 |
| Sep 2023 | 1,120,800,000 | 224,000,000 | 70,400,000 | 1,214,400,000 | 2,036,100,000 | — | 67,700,000 |
| Sep 2022 | 1,129,500,000 | 368,500,000 | 223,600,000 | 1,086,400,000 | 1,977,800,000 | — | 412,200,000 |
TTM Snapshot
Revenues TTM
$1,111,600,000
NetIncome TTM
$92,300,000
OpCashFlow TTM
$0
Assets (Latest)
$1,090,900,000
Forward EPS
$1.74
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | $197.76M | $3.22 | — |
| ANIK | Anika Therapeutics, Inc. | $198.12M | $14.89 | — |
| KRMD | KORU Medical Systems, Inc. | $192.92M | $4.20 | — |
| INFU | InfuSystem Holdings, Inc | $191.93M | $9.51 | — |
| STXS | Stereotaxis, Inc. | $190.59M | $1.95 | — |
News headlines (Yahoo Finance, 1h cache)
Embecta (EMBC) Hit With A Sharp Target Cut As Medtech Sentiment Weakens
2026-05-24 11:48 · Yahoo
Embecta acquires Owen Mumford for $172.6m
2026-05-18 11:13 · Yahoo
Embecta closes Owen Mumford acquisition for up to $201M
2026-05-18 11:10 · Yahoo
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification
2026-05-16 16:06 · Yahoo
embecta Completes Acquisition of Owen Mumford Holdings Limited
2026-05-15 13:00 · Yahoo
S&P Global Ratings Cuts Credit Rating on Embecta (EMBC) After Revenue Decline
2026-05-14 05:48 · Yahoo
Why Embecta's (NASDAQ:EMBC) Earnings Are Better Than They Seem
2026-05-13 13:28 · Yahoo
Embecta Corp. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
2026-05-08 15:25 · Yahoo
embecta to Participate at the 2026 BofA Securities Global Health Care Conference
2026-05-08 13:00 · Yahoo
Embecta (EMBC): Do Buybacks Amid Losses Reveal Capital Discipline or Strategic Uncertainty?
2026-05-06 22:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.